Because No One is Immune to the Law
September 19, 2019 - AI + Robotics, United States, FDA, Product Liability + Class Action, Pharma, Regulatory, Data Analytics

Artificial Intelligence and Pharma

Patenting Artificial Intelligence in the U.S. – Considerations for AI Companies

Bethany Hills authored an article for PHARMAnetwork, covering how the pharmaceutical industry has been adopting artificial intelligence and machine learning. Bethany discusses that the pharmaceutical sector has been one of the more robust areas where private partnerships with artificial intelligence-based technology companies have developed. She covers that many of these partnerships focus on drug design, but some also focus on drug discovery, or aspects of clinical trial or management. Bethany goes on to discuss that these partnerships are emerging in the absence of clear legal and regulatory frameworks.

Read more in PHARMAnetwork Magazine, beginning on page 54.